You searched for covid-19 | Clinical Lab Products

Why Cervical Cancer Screening Rates Are Falling—and What Could Help Reverse the Trend

Posted by Alyx Arnett | Dec 24, 2025 | Cervical (HPV) |

Despite effective prevention tools, Millennials are delaying screening. New approaches may help remove barriers to participation.

From assay validation to staffing and supply chain planning, labs can take steps to manage testing surges during flu and RSV season.

In silico analysis of 3,900 influenza sequences shows comparable sensitivity for the test against the subclade K variant currently circulating.

The version 2.0 systems feature increased throughput, expanded assay flexibility, and the ability to run up to six unique assays per run.

AI, new diagnostics, and shifting care delivery models are among the clinical laboratory predictions for 2026.